Select Page

Company to buy

  • Size: Medium
  • Sales: 10 – 30 million EUR
  • Location: Europe
  • Reason for acquisition: The management wants to expand their business
  • #CFIE PHB192

Overview of buyer for a full-service clinical research organization in Western Europe

A full-service contract research organization (CRO) is looking to acquire a suitable target that operates in the same business. Furthermore, the company provides outsourced services for pharma, biotech, medical device, and health companies. Specifically, it operates with development and sales services. In this case, a desirable target would be a company with a similar full-service focus.

Profile (strategy) of the buyer for a full-service clinical research organization in Western Europe

The company is a full-service provider of contract research services. It provides development and sales services to a wide range of companies in the health sector. For example, pharmaceutical companies, biotech companies, medical device manufacturers, and health companies, broadly. Moreover, it aims to complement clients’ strategies and augment their efficiency by enabling them to safely outsource development services with the assurance of high-quality work. Clients can thus reduce their costs and time spent on non-core activities, improving productivity.
The company’s activities include the development and distribution of a wide range of medical products, including diagnostic tests, medical devices, and pharmaceuticals. In addition, it also conducts research and provides services for drug discovery and development, as well as clinical trials. Most importantly, the company has significant experience in manifold therapeutic areas, which complements its full-service approach.
Above all, this high-quality full-service contract research organization provides services such as project management, study design, data management, biostatistics, pharmacovigilance, quality control, and monitoring.

Subscribe as an interested seller
Contact us to get details about this buyer for a full-service clinical research organization in Western Europe

Activities and products of a suitable target

The ideal target company must operate as a full-service contract research organization (CRO). However, the company must operate in Western Europe. Besides this, the ideal yearly revenue range is 10 to 30 million euros. Synergetic operations such as project management, data management, biostatistics, pharmacovigilance, quality control, etc., are highly desirable.

Highlights

  • Successful launch of innovative products
  • Partnerships with leading organizations in the industry
  • Recognition for commitment to sustainability and corporate social responsibility
  • Ongoing research and development to create new solutions for healthcare challenges
  • Dedication to improving patient outcomes and advancing the field of biotechnology

More information on this buyer for a full-service clinical research organization in Western Europe

Please get in touch if you are interested in learning more about this buyer for a full-service clinical research organization in Western Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this CRO buyer

en_GBEnglish (UK)